Remove biocon-acquires-manufacturing-facility-of-eywa-pharma
article thumbnail

Biocon acquires manufacturing facility of Eywa Pharma

Express Pharma

Biocon recently announced that its step-down, wholly-owned subsidiary, Biocon Generics has acquired Eywa Pharma’s oral solid dosage manufacturing facility, located in Cranbury, New Jersey, US, effective September 1, 2023.

Dosage 111